You are here: Industry Insights > Taro Pharmaceuticals

News List

Two lots of Phenytoin Oral Suspension voluntarily recalled europeanpharmaceuticalreview
March 11, 2020
Taro Pharmaceuticals is recalling two lots of Phenytoin Oral Suspension USP due to concerns about failure to re-suspend resulting in under or overdosing.
Taro Issues Voluntary Nationwide Recall of Lamotrigine Tablets americanpharmaceuticalreview
January 16, 2020
Taro Pharmaceuticals is voluntarily recalling one (1) lot of Lamotrigine 100 mg Tablets, Lot # 331771 (expiration date June 2021) in 100 count bottles, NDC 51672-4131-1 to the consumer level.
Taro Pharmaceuticals voluntarily recalls one lot of lamotrigine tablets europeanpharmaceuticalreview
January 14, 2020
Due to cross-contamination with enalapril maleate, Taro is voluntarily recalling one lot of its lamotrigine tablets at the consumer level.
Taro Pharmaceuticals in agreement with Thallion Pharmaceuticals financialexpress
March 21, 2017
To acquire all of the issued and outstanding shares of Thallion Pharmaceuticals